Observational Study of Canadian Patients (6 Years or Older) Receiving Dupixent® for Moderate to Severe Atopic Dermatitis

Clinical trial NCT06099704 · COMPLETED

Trial details

NCT number: NCT06099704
Sponsor: Sanofi
Status: COMPLETED
Study type: OBSERVATIONAL

Moderate to Severe Atopic Dermatitis

Start date: 2023-10-10
Primary completion: 2026-04-14
Enrollment: 305

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.